Forefront Analytics’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$416K Hold
5,319
0.45% 23
2026
Q1
$461K Buy
5,319
+1,039
+24% +$99.5K 0.42% 20
2025
Q4
$411K Buy
4,280
+135
+3% +$13.1K 0.36% 26
2025
Q3
$395K Sell
4,145
-188
-4% -$17.3K 0.38% 25
2025
Q2
$378K Buy
4,333
+1,332
+44% +$113K 0.42% 25
2025
Q1
$270K Sell
3,001
-76
-2% -$6.8K 0.31% 26
2024
Q4
$246K Buy
3,077
+754
+32% +$65.3K 0.11% 50
2024
Q3
$209K Buy
+2,323
New +$195K 0.1% 56
2024
Q2
Sell
-2,952
Closed -$257K 71
2024
Q1
$257K Buy
2,952
+516
+21% +$44K 0.12% 55
2023
Q4
$201K Buy
+2,436
New +$186K 0.1% 55
2023
Q3
Sell
-2,431
Closed -$214K 70
2023
Q2
$214K Sell
2,431
-853
-26% -$73.4K 0.12% 54
2023
Q1
$265K Sell
3,284
-305
-8% -$24.9K 0.14% 57
2022
Q4
$279K Buy
+3,589
New +$291K 0.15% 56

Other funds holding MDT

Forefront Analytics's MDT Position: Q2 2026 in Review

Forefront Analytics held its Medtronic (MDT) position steady in Q2 2026 at 5,319 shares worth $416K. The position accounts for 0.45% of the portfolio, ranked #23.

Forefront Analytics first reported a position in MDT in Q4 2022 and has held it in 13 quarters since. The position peaked at $461K in Q1 2026. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Forefront Analytics held 5,319 shares of Medtronic worth $416K as of Q2 2026.
  • Forefront Analytics left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.45% of Forefront Analytics's portfolio in Q2 2026, its #23 holding.
  • Forefront Analytics first reported a position in Medtronic in Q4 2022 and has held it in 13 quarters since.
  • Forefront Analytics's Medtronic position peaked at $461K in Q1 2026.
  • 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.